AI reads eye scans to spot thyroid disease activity and severity

NCT ID NCT07716397

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study tests whether an artificial intelligence (AI) model can accurately diagnose thyroid eye disease, assess its activity and severity, and predict its outcome using specialized MRI scans of the eye socket. Researchers will enroll 1200 people, including patients with thyroid eye disease, people with other eye conditions, and healthy volunteers. Participants undergo a detailed MRI and an eye ultrasound, and the AI analyzes the images to see if it matches expert clinical assessments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
MRI scan and ocular ultrasound with AI analysis
What this could lead to
If successful, this AI model could provide a fast, objective tool for diagnosing and monitoring thyroid eye disease, helping doctors choose the right treatment earlier.
What could go wrong
This is an observational study, not a treatment trial. The AI model may not perform as well in real-world settings as expected, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GRAVES OPHTHALMOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Shanghai Changzheng Hospital

    RECRUITING

    Shanghai, Huangpu District, 200003, China

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.